We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.42%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.1B
AUM Growth
+$2.17B
(+18%)
Cap. Flow
+$1.47B
Cap. Flow
% of AUM
10.47%
Top 10 Holdings %
Top 10 Hldgs %
18.97%
Holding
1,309
New
346
Increased
287
Reduced
265
Closed
392
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$177M |
| 2 |
Lowe's Companies
LOW
|
+$108M |
| 3 |
STJ
St Jude Medical
STJ
|
+$95.4M |
| 4 |
Newell Brands
NWL
|
+$88.6M |
| 5 |
Constellation Brands
STZ
|
+$87.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$136M |
| 2 |
UnitedHealth
UNH
|
+$99.3M |
| 3 |
PayPal
PYPL
|
+$85.4M |
| 4 |
Starbucks
SBUX
|
+$78.1M |
| 5 |
Cigna
CI
|
+$64.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.63% |
| 2 | Consumer Discretionary | 12.48% |
| 3 | Communication Services | 12.09% |
| 4 | Technology | 9.72% |
| 5 | Industrials | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
GSK
GSK
$103B
| $33.8M | 0.24% |
+627,487
| New | +$34.4M |
|
102
Mondelez International
MDLZ
$77.7B
| $33.7M | 0.24% |
+767,893
| New | +$33.7M |
|
103
Rockwell Automation
ROK
$51.4B
| $33.6M | 0.24% |
274,310
-82,867
| -23% | -$9.69M |
|
|
ALR
104
DELISTED
Alere Inc
ALR
| $32.7M | 0.23% |
756,671
-155,379
| -17% | -$6.34M |
|
105
Goodyear
GT
$2.07B
| $32.4M | 0.23% |
1,002,817
+902,125
| +896% | +$26.2M |
|
|
CTLT
106
DELISTED
CATALENT, INC.
CTLT
| $32.2M | 0.23% |
1,247,056
+786,144
| +171% | +$19.5M |
|
107
Sensient Technologies
SXT
$5.4B
| $31.2M | 0.22% |
411,916
-64,479
| -14% | -$4.73M |
|
108
Allison Transmission
ALSN
$10.1B
| $31M | 0.22% |
1,082,576
+905,771
| +512% | +$25.6M |
|
|
OPLN
109
Openlane
OPLN
$4.17B
| $31M | 0.22% |
1,900,298
+663,607
| +54% | +$10.6M |
|
110
Regions Financial
RF
$26.3B
| $31M | 0.22% |
3,144,720
-785,565
| -20% | -$7.35M |
|
|
SAGE
111
DELISTED
Sage Therapeutics
SAGE
| $31M | 0.22% |
673,539
-17,426
| -3% | -$709K |
|
|
PARA
112
DELISTED
Paramount Global Class B
PARA
| $30.5M | 0.22% |
557,436
+237,698
| +74% | +$12.6M |
|
113
Service Corp International
SCI
$11.4B
| $30.3M | 0.22% |
1,143,115
+846,298
| +285% | +$22.9M |
|
|
N
114
DELISTED
Netsuite Inc
N
| $30.2M | 0.21% |
+272,602
| New | +$27.5M |
|
115
Kirby Corp
KEX
$7.95B
| $30.1M | 0.21% |
483,659
+267,826
| +124% | +$15.4M |
|
116
Dell
DELL
$283B
| $30M | 0.21% |
+2,233,067
| New | +$30.4M |
|
117
Assured Guaranty
AGO
$3.78B
| $29.9M | 0.21% |
1,078,945
+168,846
| +19% | +$4.55M |
|
118
TechnipFMC
FTI
$30.6B
| $29.9M | 0.21% |
1,352,716
+340,466
| +34% | +$6.89M |
|
|
119
Cigna
CI
$76.6B
| $29.4M | 0.21% |
225,779
-495,683
| -69% | -$64.7M |
|
120
Zebra Technologies
ZBRA
$12.4B
| $29.3M | 0.21% |
420,698
+117,785
| +39% | +$7.24M |
|
121
Louisiana-Pacific
LPX
$5.2B
| $29.3M | 0.21% |
1,554,893
+838,213
| +117% | +$16.2M |
|
|
RAI
122
DELISTED
Reynolds American Inc
RAI
| $29.2M | 0.21% |
618,327
+134,739
| +28% | +$6.76M |
|
|
GRUB
123
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $29M | 0.21% |
337,227
-305,665
| -48% | -$22.9M |
|
124
The Mosaic Company
MOS
$7.09B
| $28.8M | 0.2% |
1,176,802
-211,741
| -15% | -$5.77M |
|
|
IDTI
125
DELISTED
Integrated Device Technology I
IDTI
| $28.7M | 0.2% |
1,244,495
+1,132,883
| +1,015% | +$23.4M |
|
Similar funds
Marshall Wace's Q3 2016 Portfolio in Review
As of Q3 2016, Marshall Wace held 1,309 positions worth $14.1B, up 18% from $11.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Marshall Wace deployed $1.47B of net new capital in Q3 2016, opening 346 new positions and adding to 287 existing holdings. Its largest new stake was St Jude Medical: 1,181,595 shares worth $94.2M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was UnitedHealth, an estimated $99.3M trimmed.
- Marshall Wace's largest Q3 2016 buy was St Jude Medical: 1,181,595 shares worth $94.2M.
- Marshall Wace added most to Zoetis in Q3 2016, an estimated $177M increase.
- Marshall Wace's biggest Q3 2016 reduction was UnitedHealth, cutting an estimated $99.3M.
- Marshall Wace fully exited EMC CORPORATION in Q3 2016, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 19% of its $14.1B portfolio in Q3 2016.
- Marshall Wace opened 346 new positions and closed 392 in Q3 2016.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $14.1B.
Based on Marshall Wace's 13F filing for Q3 2016, filed 10 Nov 2016.